Align Research Initiation of Coverage

RNS Number : 4828R
WideCells Group PLC
15 June 2018
 

15 June 2018

WideCells Group PLC ('WideCells Group' or 'the Group')

Align Research ('Align') Initiation of Coverage

 

WideCells Group PLC, the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, is pleased to announce that following the Group's recent placing, Align Research has released an update note with a Conviction Buy stance. 

 

The note covers the significant progress made by the Group in regulatory and commercial developments, overview of the rapidly growing stem cell market, use of funds from recently closed placing and Align's forecasts for the Group's future growth potential.   

To download the full note please visit: http://www.alignresearch.co.uk/cpt-company/widecells-group/

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDBGDLGGBBGIS

Companies

Iconic Labs (ICON)
UK 100

Latest directors dealings